article · BIO Web of Conferences
Artificial intelligence (AI) is being used more and more in medical diagnostics, with the potential to increase operational efficiency and diagnosis accuracy. But the use of AI also brings with it legal and regulatory ramifications, such as concerns about ethics, patient consent, and liability. The purpose of this study is to investigate how the legal system might be modified to clearly define obligations for healthcare professionals and technology innovators while defending patient rights. The approach was a thorough study of the literature that assessed the legal and regulatory implications of using AI in medical diagnosis. The research results indicated that algorithmic bias, data security, and the requirement for stringent rules to guarantee the ethical and safe application of AI are the primary obstacles. In order to guarantee equity and safety in medical practice, the study’s conclusion highlights the significance of stringent regulation and openness in the application of AI. The creation of a more stringent evaluation system, independent audits of AI algorithms, and greater transparency in data collection and use are among the regulatory policy recommendations. To enhance algorithms, modify the legal framework to safeguard patient rights, and clearly define the obligations of technology creators, more study is necessary.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1051/bioconf/202515201034
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.